Drug profile · INN
obeticholic acid
OCALIVA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
obeticholic acid (OCALIVA) is an FDA-listed pharmaceutical active ingredient. Associated with Amdipharm Mercury (Australia) Pty Limited. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN obeticholic acid
Brand OCALIVA
Route ORAL
Formulation TABLET
ATC code A05AA04
Originator Amdipharm Mercury (Australia) Pty Limited
Frequently asked questions
What is obeticholic acid?
obeticholic acid (OCALIVA) is an FDA-listed pharmaceutical active ingredient. Associated with Amdipharm Mercury (Australia) Pty Limited. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for obeticholic acid?
OCALIVA is a marketed brand name for obeticholic acid. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of obeticholic acid?
obeticholic acid has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.